Drug Type Small molecule drug |
Synonyms Indantadol, CHF 3381, CHF-3381 + [14] |
Mechanism MAO-A inhibitors(Monoamine oxidase A inhibitors), MAO-B inhibitors(Monoamine oxidase B inhibitors), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H15ClN2O |
InChIKeyJPNNIRXUJSPGRM-UHFFFAOYSA-N |
CAS Registry202914-18-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Indantadol Hydrochloride | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cough | Phase 2 | GB | 01 Oct 2009 | |
Refractory chronic cough | Phase 2 | GB | 18 Jun 2009 | |
Unexplained chronic cough | Phase 2 | GB | 18 Jun 2009 | |
Diabetic peripheral neuropathic pain | Phase 2 | US | 01 Jun 2006 | |
Diabetic peripheral neuropathic pain | Phase 2 | US | 01 Jun 2006 | |
Diabetic peripheral neuropathic pain | Phase 2 | CA | 01 Jun 2006 | |
Diabetic peripheral neuropathic pain | Phase 2 | CA | 01 Jun 2006 | |
Neuralgia | Phase 2 | - | - |